Onboarding of siponimod in secondary progressive multiple sclerosis patients in Australia: Novel, real-world evidence from the MSGo digital support programme.
Hardy TA, Aouad P, Barnett MH, Blum S, Broadley S, Carroll WM, Crimmins D, Griffiths D, Hodgkinson S, Lechner-Scott J, Lee A, Malhotra R, McCombe P, Parratt J, Plummer C, Van der Walt A, Martel K, Walker RA.
Hardy TA, et al. Among authors: lee a.
Mult Scler J Exp Transl Clin. 2024 Jan 12;10(1):20552173231226106. doi: 10.1177/20552173231226106. eCollection 2024 Jan-Mar.
Mult Scler J Exp Transl Clin. 2024.
PMID: 38222025
Free PMC article.